Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00965198 · ClinicalTrials.gov registry record
Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
A clinical trial of Bacteremia and Catheter-Related Infections, sponsored by Emory University.
- Completed
- Registry status
- 10,000
- Enrollment target
- 2
- Study locations
NCT00965198: Completed study of Bacteremia and Catheter-Related Infections, sponsored by Emory University.
NCT00965198 is a study of Bacteremia and Catheter-Related Infections that has completed, run by Emory University. The registered enrollment target is 10,000 participants, above the 6,668-participant average among 11 other Bacteremia trials with a reported enrollment target (50% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00965198, a study of Bacteremia and Catheter-Related Infections, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 10,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
Intravenous catheters are placed in nearly every hospitalized patient. These catheters, since they are breaks in skin integrity, are potential sources of infection that occur in the bloodstream. Bloodstream infections can result in higher rates of death and lengths of hospital stay, as well as increase healthcare costs. Blood is drawn or medications delivered through a catheter access device attached to the catheter. In looking at new ways to decrease infections associated with healthcare, the investigators plan to test whether the use of a silver-coated catheter access device (VLINK) compared to the standard, non-coated device (CLEARLINK) can reduce infection rates. These devices are identical in design other than the silver coating of the VLINK, that imparts a brown color to the device. Silver can prevent the growth of bacteria inside the device (biofilm formation) in the laboratory, but this has never been proven in patients. The investigators propose to do a crossover study in two Emory-owned hospitals (Emory University Hospital and Emory University Hospital at Midtown), anticipated to last 10 months. Currently, both types of devices, (standard and silver-coated) are FDA approved for clinical use and are in use at both hospitals. The investigators plan to have each hospital use only one type of catheter access device for a period of time (approximately 5 months), and then switch ("crossover") to other type of device for the rest of the study. All patients admitted to either hospital (excluding newborns and patients with infections attributed to hemodialysis catheters) will be enrolled since both devices meet the standard of care. During the study, the infection prevention department, as a continuing part of their regular duties will measure infection rates. A small subset of catheters that are removed during routine clinical care (none will be taken out solely for the study) will be sent to CDC to determine the amount of bacteria inside catheters and catheter a
Conditions Studied
Study Locations (2)
Georgia
- Emory University Hospital - Atlanta
- Emory University Hospital Midtown - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-07 |
What the finished NCT00965198 record still lists
NCT00965198 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 6,668-participant average among 11 other Bacteremia trials with a reported enrollment target (50% higher).
The record links to 2 conditions, with Bacteremia appearing as the primary indexed condition, and to 0 interventions.
NCT00965198 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00965198 about?
NCT00965198 is a clinical study titled "Comparison of Infection Rates Among Patients Using Two Catheter Access Devices". Intravenous catheters are placed in nearly every hospitalized patient. These catheters, since they are breaks in skin integrity, are potential sources of infection that occur in the bloodstream. Bloodstream infections can result in higher rates of death and lengths of hospital stay, as well as incre...
What is the current status of trial NCT00965198?
This trial is currently completed. The enrollment target is 10,000 participants. The study started on 2009-11. Estimated completion is 2011-07.
What conditions does trial NCT00965198 study?
This clinical trial studies the following conditions: Bacteremia, Catheter-Related Infections.
Who is sponsoring clinical trial NCT00965198?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00965198 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacteremia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00965198's enrollment target sits among peer trials
10,000 3rd of 11 higher than 9 of 11 other Bacteremia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bacteremia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reducing Risk for Infective Endocarditis
RECRUITING · NA
-
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge
RECRUITING
-
Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
ACTIVE NOT RECRUITING
-
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
COMPLETED
-
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness
COMPLETED · NA
-
Multicenter Blood Culture Quality Improvement
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia